Breaking News Instant updates and real-time market news.

DIS

Disney

$106.81

0.455 (0.43%)

, PCLN

Ticker changed to BKNG

$2,042.64

9.87 (0.49%)

14:17
08/08/17
08/08
14:17
08/08/17
14:17

Notable companies reporting after market close

Notable companies reporting after the market close, with earnings consensus, include Walt Disney (DIS), consensus $1.55... Priceline (PCLN), consensus $14.20... Monster Beverage (MNST), consensus 40c... Energy Transfer Equity (ETE), consensus 25c... Jazz Pharmaceuticals (JAZZ), consensus $2.75... Zillow (ZG), consensus (1c)... GoDaddy (GDDY), consensus 1c... Lions Gate (LGF.A), consensus 20c... TripAdvisor (TRIP), consensus 30c... Nuance (NUAN), consensus 27c... Hertz Global (HTZ), consensus (21c)... Red Robin (RRGB), consensus 52c.

DIS

Disney

$106.81

0.455 (0.43%)

PCLN

Ticker changed to BKNG

$2,042.64

9.87 (0.49%)

MNST

Monster Beverage

$52.87

0.16 (0.30%)

ETE

Energy Transfer Equity

$16.69

-0.6138 (-3.55%)

JAZZ

Jazz Pharmaceuticals

$155.56

-0.04 (-0.03%)

ZG

Zillow

$47.43

1.79 (3.92%)

GDDY

GoDaddy

$42.32

-0.36 (-0.84%)

LGF.A

Lionsgate

$28.25

-0.155 (-0.55%)

TRIP

TripAdvisor

$39.56

0.05 (0.13%)

NUAN

Nuance

$17.00

0.15 (0.89%)

HTZ

Hertz

$14.54

-0.7 (-4.59%)

RRGB

Red Robin

$56.85

1.05 (1.88%)

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 09

    Aug

  • 16

    Aug

  • 18

    Aug

  • 05

    Sep

  • 27

    Sep

DIS Disney
$106.81

0.455 (0.43%)

08/04/17
JEFF
08/04/17
NO CHANGE
Target $78
JEFF
Buy
Activision Blizzard building Disney-type media business, says Jefferies
Jefferies analyst Timothy O'Shea raised his price target for Activision Blizzard (ATVI) to $78 from $68 while listing five reasons to buy the stock in a post-earnings research note. The company generated $1B of in-game spending in Q2, which is a "meaningful driver" of margin expansion, O'Shea writes. He expects Destiny 2 and Call of Duty WW2 to drive strong second half of 2017 results. Activision is building a Disney-type media business for the 21st Century, argues O'Shea. He keeps a Buy rating on the shares.
06/23/17
BOFA
06/23/17
NO CHANGE
BOFA
Buy
Disney removed from US 1 list at BofA/Merrill (pre-open)
BofA/Merrill removed Disney from its US 1 list before the open. The firm keeps a Buy rating on Disney shares.
06/23/17
BOFA
06/23/17
NO CHANGE
Target $125
BOFA
Buy
Disney removed from US 1 List at BofA/Merrill
BofA/Merrill analyst Jessica Reif Cohen removed Disney from the US 1 List and lowered Q2 EBIT estimate to down 10% from up 2% to reflect reduced Consumer Products growth, increased Cable Networks and Studio Entertainment declines, , lower Theme Parks operating income, and softer Broadcasting contribution. The analyst's Q3 earnings estimate goes to $1.53 from $1.75, FY17 to $5.91 from$6.15, and FY18 to $6.70 from $7.16, and her price target goes to $125 from $134. Despite the changes, Cohen believes Disney offers best in class assets with above average growth and maintains a Buy rating.
07/18/17
RBCM
07/18/17
NO CHANGE
RBCM
Disney should be owned into Q3 results, says RBC Capital
RBC Capital analyst Steven Cahall recommends owning Disney stock into the company's Q3 results. The analyst says that the company's Q3 results "may be coming down." However, he remains upbeat on its fiscal 2018 outlook, partly due to his belief that its Parks results will beat expectations.
PCLN Ticker changed to BKNG
$2,042.64

9.87 (0.49%)

07/28/17
PIPR
07/28/17
NO CHANGE
Target $2150
PIPR
Overweight
Priceline price target raised to $2,150 from $1,900 at Piper Jaffray
Piper Jaffray analyst Michael Olson raised his price target for Priceline shares to $2,150 saying he expects a "solid" quarter when the company reports on August 8. Priceline is well positioned to capture an increasing share of travel bookings in the company's core international markets, Olson tells investors in a pre-earnings research note. He believes 2020 earnings per share of greater than $110 is achievable, if not conservative. Olson reiterates an Overweight rating on the shares.
08/01/17
FBCO
08/01/17
NO CHANGE
Target $2150
FBCO
Outperform
Priceline price target raised to $2150 from $2020 at Credit Suisse
Credit Suisse analyst Paul Bieber raised his price target for Priceline to $2150 from $2020 ahead of Q2 results. The analyst reiterates an Outperform rating on the shares.
07/18/17
MSCO
07/18/17
NO CHANGE
Target $2100
MSCO
Priceline price target raised to $2,100 from $1,950 at Morgan Stanley
Morgan Stanley analyst Brian Nowak raised Priceline's price target to $2,100 from $1,950 and increased EBITDA estimates for 2017/18 by 3%/7% to reflect continued US Booking.com strength. The analyst said Comscore analysis indicates Booking.com's US traffic growth remains strong, up 25% year-over-year in Q2, with US online bookings share growing, and larger traffic bases leading to long-term gains in share. Nowak rates Priceline an Overweight
07/11/17
PIPR
07/11/17
NO CHANGE
PIPR
Overweight
Piper survey shows 'significant increase' in Priceline market share
Piper Jaffray analyst Michael Olson says his firm's survey of 1,000 U.S. consumers increases his confidence in his Overweight ratings on Priceline (PCLN) and Expedia (EXPE). The survey shows a "significant increase" in market share for Priceline brands, "stability" for Expedia brands and a decline in the number of people who either book direct on a hotel website or do not book travel online at all, Olson tells investors in a research note. He reiterates Overweight ratings on both Priceline and Expedia and maintains a Neutral rating on TripAdvisor (TRIP).
MNST Monster Beverage
$52.87

0.16 (0.30%)

06/20/17
JEFF
06/20/17
NO CHANGE
Target $63
JEFF
Buy
Monster Beverage looks attractively valued, says Jefferies
Jefferies analyst Kevin Grundy says Monster Beverage remains a top pick following "upbeat commentary" at the company's shareholder meeting. Positives included "bullish" commentary on international growth and margin, an "encouraging" U.S. outlook, and long-term drivers to grow penetration, Grundy tells investors in a research note. He views the shares as attractively valued and reiterates a Buy rating on Monster with a $63 price target.
06/01/17
JEFF
06/01/17
NO CHANGE
JEFF
Jefferies reiterates Monster, Newell as top picks
Jefferies analyst Kevin Grundy reiterates Monster Beverage (MNST) and Newell Brands (NWL) as top picks while addressing "common investor pushbacks." For Monster, the analyst believes improving U.S. results, continued strong international growth and M&A optionality should lead to continued outperformance. For Newell, the analyst sees an attractive valuation and improving organic sales growth. He reiterates Buy ratings on both names.
06/20/17
UBSW
06/20/17
NO CHANGE
Target $59
UBSW
Buy
Monster Beverage growth runway remains attractive, says UBS
UBS analyst Stephen Powers said the Monster Beverage shareholder meeting was highlighted by an upbeat management tone. The team sees its growth coming from international distribution and its top-line growth driven by select innovation, he noted. Powers reiterated his Buy rating and raised his price target to $59 from $57 on Monster Beverage shares.
07/19/17
JEFF
07/19/17
NO CHANGE
JEFF
Jefferies lays out stocks 'overly discounting' Amazon risk
Amazon.com's (AMZN) planned purchase of Whole Foods Market (WFM) has further widened the valuation spread between consumer stocks the market views as resistant to the Aamzon threat and those viewed as vulnerable, Jefferies analysts including Andy Barish and Daniel Binder tells investors in a research note. They believe this dynamic has created opportunities. Specifically, the analysts feel shares of Wal-Mart (WMT), Hain Celestial (HAIN), Foot Locker (FL) and Advance Auto Parts (AAP) are "overly discounting" potential risk from Amazon. Jefferies also believes Casey's General Stores (CASY), Lamb Weston (LW), Murphy USA (MUSA), Monster Beverage (MNST), Starbucks (SBUX) and Ulta Beauty (ULTA) are "well insulated" from Amazon disruption.
ETE Energy Transfer Equity
$16.69

-0.6138 (-3.55%)

05/10/17
BERN
05/10/17
UPGRADE
BERN
Outperform
Energy Transfer Equity upgraded to Outperform from Market Perform at Bernstein
07/13/17
STFL
07/13/17
INITIATION
STFL
Buy
Energy Transfer Equity initiated with a Buy at Stifel
Stifel analyst Selman Akyol started coverage of Energy Transfer Equity with a $20 price target and a Buy rating. The analyst predicts that the company's distributable cash flow will jump more than 70% in 2018, and he says that the owner of the Energy Transfer family of companies is "predominately aligned" with Energy Transfer Equity.
05/10/17
BERN
05/10/17
UPGRADE
BERN
Outperform
Energy Transfer Equity, Energy Transfer Partners upgraded at Bernstein
As noted earlier, Bernstein upgraded Energy Transfer Equity (ETE) and Energy Transfer Partners (ETP) to Outperform from Market Perform. Analyst Jean Ann Salisbury says that the companies are "arguably levered" to three growth areas: Permian, Marcelllus, and ethane volumes. The analyst adds that several "very positive developments" for the companies have occurred since January: the DAPL project proceeded and its "finish line is in sight; progress was made with the Rover project; the DEP approved Mariner East 2; and 73 rigs were added in the Permian, while oil production there rose meaningfully. Target $23 for Energy Transfer Equity and $30 for Energy Transfer Partners.
05/12/17
WOLF
05/12/17
INITIATION
Target $20
WOLF
Peer Perform
Energy Transfer Equity initiated with a Peer Perform at Wolfe Research
Wolfe Research initiated Energy Transfer Equity with a Peer Perform and a $20 price target.
JAZZ Jazz Pharmaceuticals
$155.56

-0.04 (-0.03%)

06/07/17
JPMS
06/07/17
NO CHANGE
JPMS
Overweight
Jazz Pharmaceuticals data beat investor expectations, says JPMorgan
JPMorgan analyst Jessica Fye believes full results from the Phase III JZP-110 narcolepsy and obstructive sleep apnea studies established a "compelling clinical profile" and beat investor expectations. JZP-110 represents a long-term growth driver outside of Xyrem, Fye tells investors in a research note. She believes the current valuation does not fully the double-digit growth she expects Jazz to generate over the next several years. The analyst reiterates an Overweight rating on the shares.
08/03/17
BMOC
08/03/17
NO CHANGE
BMOC
Outperform
Vyxeos label an 'upside suprise' for Jazz, says BMO Capital
BMO Capital analyst Gary Nachman said the FDA approval of Jazz Pharmaceuticals' Vyxeos for "poor-prognosis" AML patients came "on the earlier side of expectations" and with the "upside surprise" that there are no age restrictions in the label indication. The analyst, who said he is still bullish on the prospects for Vyxeos, keeps an Outperform rating on Jazz shares.
06/07/17
COWN
06/07/17
NO CHANGE
Target $190
COWN
Outperform
Cowen tells investors to be involved now in Jazz Pharmaceuticals
Cowen analyst Ken Cacciatore noted Jazz Pharmaceuticals presented positive Phase lll data on its drug candidate to treat daytime sleepiness and said the results were as good as could be hoped for. Given its efficacy/safety profile, he believes JZP-110 is "best-in-class" and likely a $750M product and recommends investors get involved now. Cacciatore reiterated his Outperform rating and $190 price target on Jazz Pharmaceuticals shares.
08/08/17
COWN
08/08/17
NO CHANGE
Target $190
COWN
Outperform
Jazz Pharmaceuticals assets undervalued, says Cowen
Cowen analyst Ken Cacciatore said Jazz Pharmaceuticals provided input from clinical consultants and its own commentary on Vyxeos, which increased conviction in the drug. Cacciatore, who believes the totality of its assets are undervalued, reiterated his Outperform rating and $190 price target on Jazz shares.
ZG Zillow
$47.43

1.79 (3.92%)

07/18/17
07/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zillow (Z, ZG) initiated with a Sector Weight at KeyBanc. 2. Electronic Arts (EA) and Activision Blizzard (ATVI) were initiated with a Buy at Needham. 3. Infinera (INFN) initiated with a Buy at Craig-Hallum. 4. Baker Hughes (BHGE) reinstated with a Sell at Goldman Sachs. 5. Acadia (ACHC) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/05/17
NEED
05/05/17
NO CHANGE
Target $48
NEED
Buy
Zillow price target raised to $48 from $41 at Needham
Needham analyst Kerry Rice raised his price target for Zillow to $48 from $41 after the company reported "strong Q1" revenue and EBITDA upside. The analyst reiterates a Buy rating on the shares.
07/17/17
KEYB
07/17/17
INITIATION
KEYB
Sector Weight
Zillow initiated with a Sector Weight at KeyBanc
06/22/17
CHLM
06/22/17
INITIATION
Target $58
CHLM
Buy
Zillow assumed with a Buy at Craig-Hallum
Craig-Hallum analyst Bradley Berning assumed coverage of Zillow with a Buy rating and $58 price target, citing its potential to disrupt real estate lead generation.
GDDY GoDaddy
$42.32

-0.36 (-0.84%)

06/15/17
PIPR
06/15/17
NO CHANGE
Target $50
PIPR
Overweight
Piper positive on GoDaddy after day with management
After spending a day with management, Piper Jaffray analyst Samuel Kemp calls GoDaddy the "highest quality compounding growth story in our SMid cap coverage." The analyst believes the stock is undervalued and reiterates an Overweight rating on the name with a $50 price target. The company's "increasingly diversified" sources of new customer growth and new GoCentral offering reduce the likelihood of a bookings growth fall-off, Kemp tells investors in a research note.
07/20/17
PIPR
07/20/17
NO CHANGE
Target $44
PIPR
Overweight
Piper says Google 'bark-with-no-bite' site builder unlikely to hurt GoDaddy
Piper Jaffray analyst Samuel Kemp noted today's 2% slide in GoDaddy (GDDY) shares, which he attributes to investor attention being drawn to a website builder tool quietly launched by Google (GOOG) a month ago. However, Kemp believes the rudimentary, "bark-with-no-bite" product is unlikely to impact GoDaddy's existing subscriber base and future growth and would be a buyer of GoDaddy shares on the pullback. He keeps an Overweight rating and $44 price target on GoDaddy shares.
03/28/17
LEHM
03/28/17
INITIATION
Target $45
LEHM
Overweight
GoDaddy initiated with an Overweight at Barclays
Barclays analyst Deepak Mathivanan initiated GoDaddy with an Overweight and a $45 price target.
05/16/17
PIPR
05/16/17
NO CHANGE
Target $50
PIPR
Overweight
GoDaddy price target raised to $50 from $46 at Piper Jaffray
Piper Jaffray analyst Samuel Kemp raised his price target for GoDaddy to $50 after analyzing the value of the company's "compounding growth." The analyst is "incrementally more bullish" on GoDaddy's ability to meet and likely exceed its 2018 free cash flow target of $600M. He reiterates an Overweight rating on the shares.
LGF.A Lionsgate
$28.25

-0.155 (-0.55%)

07/21/17
07/21/17
NO CHANGE

Lionsgate price target raised to $36 from $29 at Loop Capital
Loop Capital analyst David Miller said that while Lionsgate shares have grinded higher as the company "continues to do what it has always done very well," he also has confidence that it is well ahead of plan on Starz synergies and that it has potential from "second-window" sales of streaming rights and orders from OTT platforms. Miller raised his price target on Lionsgate B shares to $36 from $29 and keeps a Buy rating on the name.
06/02/17
06/02/17
UPGRADE
Target $31

Buy
Lionsgate upgraded to Buy at SunTrust
As previously reported, SunTrust upgraded Lionsgate (LGF.B) to Buy from Hold and raised its price target to $31 from $28. Analyst Matthew Thornton said expectations into the Q4 report were cautious as evidenced by the stock reaction to earnings, despite FY18 OIBDA guidance that was 3% below consensus. Now that FY18 OIBDA, Motion Pictures, and TV Production expectations have been re-based, Thornton believes estimates are now achievable, and said Starz's upcoming original releases should help sub growth near-term. The analyst said deleveraging is ahead of plan and could result in buybacks in FY19, and continues to expect ongoing consolidation of content and distribution, making Lionsgate a target given its assets and size.
06/27/17
DBAB
06/27/17
INITIATION
Target $29
DBAB
Hold
Lionsgate initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Bryan Kraft started Lionsgate Class A (LGF.A) shares with a Hold rating and $29 price target. The analyst views consensus estimates as too high but sees potential upside through consolidation.
06/27/17
06/27/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. JPMorgan analyst Alex Yao resumed coverage of Alibaba (BABA) Group with an Overweight rating and $190 price target following a period of restriction. The rating is unchanged and the price target is raised from $140. 2. SunTrust analyst Terry Tillman initiated Salesforce (CRM) with a Buy and a $110 price target and views its as a core holding for large-cap investors. 3. Citi analyst Joel Beatty started Arena Pharmaceuticals (ARNA) with a Buy rating and $23 price target. 4. Deutsche Bank analyst Bryan Kraft started Lionsgate Class A (LGF.A) shares with a Hold rating and $29 price target. 5. Cantor Fitzgerald analyst Louise Chen assumed coverage of Amarin (AMRN) with an Overweight rating and $10 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TRIP TripAdvisor
$39.56

0.05 (0.13%)

07/19/17
07/19/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Boeing (BA) upgraded to Neutral from Underperform at BofA/Merrill with analyst Ronald Epstein citing stronger free-cash-flow generatoin and the impact from large share buybacks. 2. Vertex (VRTX) upgraded to Buy from Neutral at Janney Capital, to Outperform from Market Perform at Raymond James and Cowen, and to Overweight from Equal Weight at Barclays. 3. Chipotle (CMG) upgraded to Outperform from Market Perform at Telsey Advisory with analyst Bob Derrington saying yesterday's pullback in shares, combined with management's more aggressive menu innovation plan, provides a buying opportunity. 4. TripAdvisor (TRIP) upgraded to Market Perform from Underperform at Cowen. 5. First Solar (FSLR) upgraded to Buy from Hold at Axiom with analyst Gordon Johnson II saying that his checks suggest the company has delayed its transition to Series 6 technology as it runs its Series 4 production lines longer to accommodate increased demand. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/17
COWN
07/19/17
UPGRADE
COWN
Market Perform
TripAdvisor upgraded to Market Perform from Underperform at Cowen
07/12/17
WELS
07/12/17
INITIATION
WELS
Market Perform
trivago initiated with a Market Perform at Wells Fargo
Wells Fargo is upbeat on Trivago's (TRVG) execution and business model. But it is cautious on the stock due to what its says is the stock's above peer valuation and increasing competition from TripAdvisor (TRIP).
NUAN Nuance
$17.00

0.15 (0.89%)

06/12/17
DBAB
06/12/17
NO CHANGE
Target $25
DBAB
Buy
Nuance's new products double addressable market, says Deutsche Bank
Deutsche Bank analyst Nandan Amladi believes Nuance's new healthcare products "significantly expand" the company's market opportunity. New software that uses clinical language understanding techniques on transcribed notes to ensure that the documentation is complete doubles Nuance's market opportunity to about $5B, Amladi tells investors in a research note. He reiterates a Buy rating on the shares with a $25 price target.
06/29/17
CHLM
06/29/17
NO CHANGE
Target $24
CHLM
Buy
Nuance growth engine in healthcare not affected by hack, says Craig-Hallum
Craig-Hallum analyst Jeff Van Rhee noted that Nuance has been impacted by the "NotPetya" ransomware attack, though "very importantly" the hack doesn't appear to have affected Dragon Cloud services, which he identifies as the company's critical growth engine within healthcare. In fact, the opening of this platform for legacy transcription customers who have been impacted by the hack may accelerate their migration to Dragon Cloud, Van Rhee tells investors. While potential lost revenue from legacy transcription is meaningful, the analyst sees reputational risk as the larger issue and views it as "noteworthy" that the Dragon product has remained online. He keeps a Buy rating and $24 price target on Nuance shares.
01/06/17
LEHM
01/06/17
UPGRADE
Target $19
LEHM
Overweight
Nuance upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Saket Kalia upgraded Nuance Communications to Overweight calling the company a turnaround pick for 2017. The analyst sees limited downside from current share levels and sees 2017 as the revenue growth. Kalia raised his price target for the shares to $19 from $17.
11/18/16
RAJA
11/18/16
UPGRADE
RAJA
Strong Buy
Nuance upgraded to Strong Buy from Outperform at Raymond James
HTZ Hertz
$14.54

-0.7 (-4.59%)

08/04/17
08/04/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Neutral at Wedbush. 2. Avis Budget (CAR) was initiated with an Overweight at JPMorgan while Hertz (HTZ) was initiated with a Neutral at the firm. 3. IBM (IBM) initiated with a Neutral at Wedbush. 4. Amtech Systems (ASYS) initiated with a Buy at Roth Capital. 5. Franklin Financial Network (FSB) initiated with a Market Perform at Hovde Group. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/17
JPMS
08/04/17
INITIATION
Target $15
JPMS
Neutral
Hertz initiated with a Neutral at JPMorgan
JPMorgan analyst Samik Chatterjee started Hertz with a Neutral rating and $15 price target. The analyst believes greater profit growth is possible but sees higher execution risk.
07/31/17
LEHM
07/31/17
DOWNGRADE
Target $9
LEHM
Underweight
Hertz downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Brian Johnson downgraded Hertz Global Holdings to Underweight with an unchanged price target of $9. Fundamentals may have bottomed, but the stock is ignoring the challenges ahead in the company's earnings recovery following the nearly 100% rally since June 21, Johnson tells investors in a research note. He expects a "sharp miss" relative to expectations when Hertz reports Q2 results.
07/31/17
07/31/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Facebook (FB) downgraded to Sell from Hold at Pivotal Research with analyst Brian Wieser saying the shares are not factoring in risks to the company's growth following their "remarkable run" this year. 2. Ulta Beauty (ULTA) downgraded to Perform from Outperform at Oppenheimer with analyst Rupesh Parikh saying softer commentary from L'Oreal on its earnings call, increasing promotional activity from the department store channel, and more difficult year-over-year comparisons "could now signal a potentially more challenging beauty backdrop going forward." 3. Hertz (HTZ) downgraded to Underweight from Equal Weight at Barclays with analyst Brian Johnson saying fundamentals may have bottomed, but the stock is ignoring the challenges ahead in the company's earnings recovery following the nearly 100% rally since June 21. 4. Citi (C) downgraded to Market Perform from Outperform at BMO Capital with analyst James Fotheringham citing valuation and lack of catalysts. 5. Visteon (VC) downgraded to Neutral from Buy at UBS with analyst Colin Langan saying the risk/reward is more balanced with the shares up 60% over the last year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
RRGB Red Robin
$56.85

1.05 (1.88%)

05/11/17
MAXM
05/11/17
NO CHANGE
Target $75
MAXM
Buy
Red Robin price target raised to $75 ahead of earnings at Maxim
Maxim analyst Stephen Anderson raised his price target on Red Robin to $75 from $70 ahead of the company's Q1 report on May 16, though he lowered his Q1 EPS view to 61c from 67c and cut his same-restaurant sales estimate to down 2.9% from down 2.7%. He anticipates easier comparisons on sales as 2017 progresses raised his 2018 EPS estimate and expects management to emphasize shareholder returns rather than unit growth, he tells investors. Anderson keeps a Buy rating on Red Robin shares.
05/17/17
BOFA
05/17/17
UPGRADE
Target $80
BOFA
Buy
Red Robin upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Gregory Francfort upgraded Red Robin to Buy and raised its price target to $80 from $65 following the solid Q1 report. The analyst said Red Robin is showing signs of stabilization and believes the the grater focus on ROIC and store level margins will drive share higher.
05/26/17
ADAM
05/26/17
UPGRADE
Target $90
ADAM
Buy
Red Robin upgraded to Buy from Hold at Canaccord
Canaccord analyst Lynne Collier upgraded Red Robin to Buy from Hold to reflect greater confidence in its top-line drivers and in stable to improving casual dining trends. The analyst said the top line should improve with the company's focus on value and curbside pickup and the potential for it to turn comps positive. Collier raised her price target to $90 from $72 on Red Robin shares.
05/26/17
05/26/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. GlaxoSmithKline (GSK) upgraded to Buy from Hold at Berenberg with analyst Alistair Campbell saying Glaxo's long-term value is emerging and the market underappreciates the strength and breadth of its diversified business. 2. Rayonier Advanced Materials (RYAM) was upgraded to Buy from Hold at Vertical Research and to Buy from Neutral at BofA/Merrill. 3. Red Robin (RRGB) upgraded to Buy from Hold at Canaccord with analyst Lynne Collier citing greater confidence in its top-line drivers and in stable to improving casual dining trends. Collier raised her price target to $90 from $72 on Red Robin shares. 4. Star Bulk Carriers (SBLK) upgraded to Buy on valuation at Seaport Global with analyst Magnus Fyhr citing the pullback in shares and favorable drybulk market fundamentals. Fyhr raised his price target on Star Bulk shares to $13 from $11.50. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ABT

Abbott

$72.00

0.57 (0.80%)

14:50
09/25/18
09/25
14:50
09/25/18
14:50
Hot Stocks
Abbott says study shows Portico safely reduced severe aortic stenosis »

Abbott announced one-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 17

    Oct

NKE

Nike

$85.02

0.75 (0.89%)

14:49
09/25/18
09/25
14:49
09/25/18
14:49
Options
Nike options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EZPW

Ezcorp

$10.58

0.075 (0.71%)

14:45
09/25/18
09/25
14:45
09/25/18
14:45
Conference/Events
Ezcorp management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 06

    Nov

CNDT

Conduent

$22.30

0.12 (0.54%)

14:37
09/25/18
09/25
14:37
09/25/18
14:37
Conference/Events
Conduent management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

INTC

Intel

$46.14

-0.77 (-1.64%)

, ADI

Analog Devices

$92.82

-2.19 (-2.31%)

14:36
09/25/18
09/25
14:36
09/25/18
14:36
Hot Stocks
Intel slides as analyst says sell with semis seen in cyclical downturn »

Shares of Intel (INTC)…

INTC

Intel

$46.14

-0.77 (-1.64%)

ADI

Analog Devices

$92.82

-2.19 (-2.31%)

MCHP

Microchip

$79.10

-3.19 (-3.88%)

ON

ON Semiconductor

$18.44

-0.665 (-3.48%)

MPWR

Monolithic Power

$129.88

-2.99 (-2.25%)

AMD

AMD

$32.59

-0.03 (-0.09%)

NVDA

Nvidia

$268.05

2.33 (0.88%)

QCOM

Qualcomm

$73.16

-0.43 (-0.58%)

SIMO

Silicon Motion

$54.13

-0.04 (-0.07%)

MXIM

Maxim Integrated

$58.13

-1.61 (-2.70%)

TXN

Texas Instruments

$107.78

-2.03 (-1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 04

    Oct

  • 08

    Oct

  • 22

    Oct

  • 10

    Dec

  • 08

    May

BRC

Brady

$44.20

0.15 (0.34%)

14:35
09/25/18
09/25
14:35
09/25/18
14:35
Hot Stocks
Brady director Elizabeth Bruno sells over $1M in company stock »

Brady director Elizabeth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$67.05

(0.00%)

, GBNK

Guaranty Bancorp

$29.95

(0.00%)

14:25
09/25/18
09/25
14:25
09/25/18
14:25
Conference/Events
Guaranty Bancorp to host special shareholder meeting »

Special Shareholder…

IBTX

Independent Bank

$67.05

(0.00%)

GBNK

Guaranty Bancorp

$29.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

14:20
09/25/18
09/25
14:20
09/25/18
14:20
General news
FOMC began its 2-day meeting and will announce its decision at 14 ET Wednesday »

FOMC began its 2-day…

CRM

Salesforce

$158.62

-0.235 (-0.15%)

, AAPL

Apple

$222.01

1.22 (0.55%)

14:19
09/25/18
09/25
14:19
09/25/18
14:19
Hot Stocks
Salesforce Co-CEO Benioff says 'economy is still ripping' »

Marc Benioff is being…

CRM

Salesforce

$158.62

-0.235 (-0.15%)

AAPL

Apple

$222.01

1.22 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 03

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/25/18
09/25
14:17
09/25/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/25/18
09/25
14:16
09/25/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRS

Antares Pharma

$3.47

0.175 (5.31%)

14:10
09/25/18
09/25
14:10
09/25/18
14:10
Options
5-strike call buyers in Antares Pharma and implied volatility spikes »

5-strike call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

FB

Facebook

$165.12

-0.285 (-0.17%)

14:06
09/25/18
09/25
14:06
09/25/18
14:06
Periodicals
Facebook likely to pick Adam Mosseri to head Instagram, The Information says »

Facebook will likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 07

    Nov

PAYX

Paychex

$73.06

-1.5 (-2.01%)

, ADP

ADP

$147.62

-1.5 (-1.01%)

14:04
09/25/18
09/25
14:04
09/25/18
14:04
Recommendations
Paychex, ADP, Square analyst commentary  »

New Square payroll app…

PAYX

Paychex

$73.06

-1.5 (-2.01%)

ADP

ADP

$147.62

-1.5 (-1.01%)

SQ

Square

$94.22

8.16 (9.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 11

    Oct

  • 22

    Oct

  • 31

    Oct

  • 26

    Nov

NTES

NetEase

$214.55

4.41 (2.10%)

14:00
09/25/18
09/25
14:00
09/25/18
14:00
Upgrade
NetEase rating change  »

Follow-up: NetEase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$147.41

-1.71 (-1.15%)

13:55
09/25/18
09/25
13:55
09/25/18
13:55
Options
ADP put volume heavy and directionally bearish »

Bearish flow noted in ADP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

GTS

Triple-S

$20.33

-0.7 (-3.33%)

13:50
09/25/18
09/25
13:50
09/25/18
13:50
Hot Stocks
Triple-S finalizes contract with Government of Puerto Rico on Medicaid plan »

Triple-S Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

NTES

NetEase

$214.61

4.47 (2.13%)

13:47
09/25/18
09/25
13:47
09/25/18
13:47
Upgrade
NetEase rating change  »

NetEase upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$182.29

5.41 (3.06%)

, GOOG

Alphabet

$1,184.00

10.62 (0.91%)

13:46
09/25/18
09/25
13:46
09/25/18
13:46
Periodicals
Spotify asks EU for stronger regulations against U.S. rivals, Reuters reports »

Driven by concerns over…

SPOT

Spotify

$182.29

5.41 (3.06%)

GOOG

Alphabet

$1,184.00

10.62 (0.91%)

GOOGL

Alphabet Class A

$1,192.91

13.13 (1.11%)

AMZN

Amazon.com

$1,957.44

22.94 (1.19%)

EBAY

eBay

$32.72

-1 (-2.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

HIMX

Himax

$5.87

-0.03 (-0.51%)

13:45
09/25/18
09/25
13:45
09/25/18
13:45
Options
Himax call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
09/25/18
09/25
13:45
09/25/18
13:45
General news
FOMC Forecast revisions »

FOMC Forecast revisions…

SHOP

Shopify

$163.33

1.06 (0.65%)

, AMZN

Amazon.com

$1,957.00

22.5 (1.16%)

13:43
09/25/18
09/25
13:43
09/25/18
13:43
Periodicals
Shopify CEO welcomes competition from Amazon, Bloomberg reports »

Shopify's (SHOP) CEO…

SHOP

Shopify

$163.33

1.06 (0.65%)

AMZN

Amazon.com

$1,957.00

22.5 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 13

    Nov

CHRS

Coherus Biosciences

$16.35

0.3 (1.87%)

13:40
09/25/18
09/25
13:40
09/25/18
13:40
Hot Stocks
Coherus Biosciences receives European Commission approval for UDENYCA »

Coherus BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 03

    Nov

LMT

Lockheed Martin

$344.92

7.27 (2.15%)

13:36
09/25/18
09/25
13:36
09/25/18
13:36
Hot Stocks
U.S. Army awards Lockheed Martin $289M HIMARS contract »

The U.S. Army awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

KMX

CarMax

$76.31

0.43 (0.57%)

13:35
09/25/18
09/25
13:35
09/25/18
13:35
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.